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Introduction:
During open radical cystectomy (RC) combined with pelvic lymph node dissection (PLND) and urinary diversion (UD), bleeding from the local pelvic venous plexus and capillaries surrounding the bladder and prostate may be substantial despite meticulous surgery. Strategies to reduce blood loss need to be developed aiming to reduce the incidence of blood transfusion and improve postoperative outcome. In the frame of a prospective randomized trial, we recently showed that an intraoperative preemptive norepinephrine administration combined with a restrictive deferred hydration significantly reduces postoperative complications, blood loss and the need for blood transfusion 1, 2 . Whether this is due to a decreased local venous pressure or other factors (vasoconstriction or minimal change in the concentration of coagulation factors) is not known. Local venous pressure in the surgical field may influence blood loss. Low (<5 mmHg) central venous pressure (CVP) is considered a simple and potent method to minimize intraoperative blood loss during liver resection surgery [3] [4] [5] . Therefore, we investigated whether blood loss also correlates with pelvic venous pressure (PVP), a surrogate for the local venous pressure around the bladder and prostate, during open RC combined with PLND and UD under two different intraoperative fluid management strategies: a preemptive norepinephrine infusion combined with a restrictive deferred hydration or a more liberal hydration without norepinephrine. In addition, the impact of abdominal packing on PVP was analysed.
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Methods
Trial design and participants
This randomized double-blind single-centre study was approved by the local ethics committee (KEK Bern) and registered at Clinicaltrials.gov (NCT01276665). Patients with an ASA score of II to III were included. Exclusion criteria were coagulopathies, significant hepatic and renal dysfunction (Kidney Disease Outcomes Quality Initiative stage ≥3), congestive heart failure and contraindication for thoracic epidural 
Initial randomization and blinding:
The protocol and design of the original study has been described previously 1 . Briefly, patients were randomly allocated to the norepinephrine/low-volume group or to the control group by using a computer generated permuted block randomization with 1:1 allocation.
Surgeons, patients and data assessors were blinded to the assigned fluid regimens.
Crystalloids bags and perfusions pumps were hidden behind a sterile curtain during
surgery. Assessors of the postoperative data had no access to the anesthesiologic patients' data.
Patient management
Standard monitoring included continuous ECG, heart rate, core temperature, S p O 2 , invasive mean arterial pressure (MAP) and CVP. Before induction of anesthesia, an epidural catheter was placed at the T9/T10 level and activated with bupivacaine 0.25% at a rate of 8 ml/h until the end of the PLND. Anesthesia was induced with propofol, fentanyl, rocuronium and maintained with isoflurane. Ventilation with an inspired oxygen fraction of 60% was mechanically controlled to maintain normocapnia. Normothermia was maintained with an air warming system and fluid warmer.
In the norepinephrine/low-volume group, a preemptive norepinephrine infusion was started at 2 µg/kg/h after the induction of anesthesia and 1 ml/kg/h of a balanced crystalloid solution (Ringerfundin®, B. Braun Medical AG, Sempach, Switzerland) was administrated until the bladder had been removed, followed by 3 ml/kg/h of crystalloid until the end of surgery while maintaining the norepinephrine infusion. In case of hypotension (i.e. MAP <60 mmHg), the norepinephrine infusion was titrated accordingly after an initial bolus of 10 µg. In the control group, a bolus of 6 ml/kg of crystalloid was administrated during induction of anesthesia, followed by 6 ml/kg/h of balanced crystalloid solution intraoperatively. In this group, episodes of hypotension were treated with boluses of 250 ml of crystalloid solution. In all patients, blood units were only transfused when the hemoglobin was <8.0 gr/dl
Patients were in 30° head-down position during the whole duration of surgery. The surgical technique was standardized 7, 8 . At least one of 3 senior urologists (FCB, GNT, UES) was present during surgery. 
Data collection and outcome measures
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Patients were analyzed in subgroups according to whether their PVP at the end of the cystectomy part was associated with a clinically relevant blood loss, (i.e. need for blood unit transfusion).
Statistical analysis
Data were analyzed using non-parametric statistical models. Data are expressed as median values with ranges or numbers (%). Categorical data were compared with the chi square test. Relative risks (RR) and 95% CI were also calculated when appropriate. Continuous data were compared using the two-tailed Mann-Whitney U test and Kruskal-Wallis H test followed by the Bonferroni correction for multiple comparisons. Within each group, the within patient's PVP values with and without gauzes were analyzed using the Wilcoxon signed rank tests. Spearman correlation tests were used to test the correlation between blood loss and MAP, CVP and PVP at the different time points. Test results were considered significant if P <0.05. Receiver operating characteristic (ROC) curves were constructed to identify the optimal cut-off values for association between blood loss and the need for blood unit transfusion (defined as clinically relevant blood loss) and then between mean PVP and clinically relevant blood loss. The optimal cut-off was defined as the value associated with the highest sum of sensitivity and specificity (Youden's index). Multiple logistic regression analyses using a forward selection procedure were applied to identify independent risk factors for relevant blood loss and reported as adjusted odds ratios (ORs) with 95% CIs. Factors were included if their P values were smaller than 0.10.
Confounders considered were mean MAP, CVP and PVP. No interaction terms were included due to the sample size. The fit and predictive power of the model was assessed using the Hosmer-Lemeshow goodness-of-fit test and ROC-area under the curve (ROC-AUC).
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Results
PVP was assessed in 82 in the norepinephrine/low-volume group and 81 patients in the control group (Figure 1 ). Baseline data were equally distributed between the subgroups within the groups ( Table 1 ).
The ROC-AUC for mean PVP was 0.753 (95% CI 0.659-0.847) according to the occurrence of blood loss requiring blood unit transfusions. The optimal cut-off value for mean PVP was 5.1 mmHg (84% sensitivity and 64% specificity) for discrimination of patients with a relevant blood loss. According to multiple logistic regression analysis, PVP (<5 vs ≥5 mmHg) was the only independent predictor for clinically (Table 2 ).
There was a significant difference in the rate of blood unit transfusion given between the patients with a PVP <5 mmHg and patients with a PVP ≥5 mmHg ( 
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Discussion
Total intraoperative blood loss was significantly lower in patients with a low PVP (<5 mmHg) compared to patients with a PVP ≥5 mmHg. A significantly larger number of patients with a preemptive infusion of norepinephrine combined with a restrictive deferred hydration had a PVP <5 mmHg. Even in this group, increased PVP was associated with an increased blood loss. This suggests that fluid management can influence PVP and consequently impact blood loss.
Blood loss during open RC with UD has an impact on postoperative outcome and increases postoperative morbidity [9] [10] [11] [12] . Blood unit transfusion following excessive blood loss carries the risk of transfusion associated lung injury, postoperative transfusion associated fluid overload, increased wound infection rates and has been postulated to promote cancer recurrence [13] [14] [15] . Consequently, intraoperative strategies aiming to reduce blood loss may have vital consequences.
Little is known about the impact of the venous pressure in the surgical site on blood loss. Substantial literature could already demonstrate that a significant reduction in blood loss can be achieved by maintaining a CVP lower than 5 mmHg in patients undergoing liver dissection and thus making control of vascular injury easier 3, 4 . In this study we could demonstrate that preemptive use of norepinephrine with a restrictive deferred fluid management lead to a significant reduction in PVP and blood loss when compared with a more liberal fluid regimen. 16, 17 . For these reasons this approach has been recommended for high-risk patients [17] [18] [19] [20] .
Another important observation was the lack of correlation between PVP and CVP, with the exception of a weak correlation at the end of the cystectomy part. Thus, standard CVP assessment may not be a reliable surrogate for PVP, a factor which has to be taken into account.
In some of our patients negative PVPs were measured which could potentially be a risk for air emboli. However, a Trendelenburg's position of 30 degrees and packing of the pelvis with wet gauzes after removing the bladder should limit the risk of air emboli. In addition, no fall in end-tidal carbon dioxide could be detected, thus making clinically relevant air emboli unlikely.
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Limitations: The main limitation is the lack of a specific power analysis concerning the reduction in blood loss as this study is a secondary analysis. In addition, PVP measurements were only done punctually and not continuously. However, continuous monitoring of PVP would imply catheterization of the veins resulting in a higher risk of thrombosis.
Conclusion:
Our results suggest that low PVP during PLND, RC and UD significantly reduces No 39 29%M A N U S C R I P T 
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